SI-BONE EBIT

As of the most recent data (June 2026), SIBN shows a EBIT of $-15M. That compares with $-23M in the prior-year period — up 34.7% year over year. That is below the Healthcare sector average of $23B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SIBN's EBIT is now $-15M (was $-23M) — a 34.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether SI-BONE is outperforming or lagging.

The Healthcare sector average EBIT is about $23B. SI-BONE is at $-15M, which is lower that average. That is roughly 100.1% below the sector mean. Use the comparison chart on this page to see how SIBN stacks up against individual peers as well.

Tracking SIBN's ebit over time shows whether SI-BONE is scaling, shrinking, or reshaping that part of the business. The current reading is $-15M That compares with $-23M in the prior-year period — up 34.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has SI-BONE's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-15M) with ownership activity and broader fundamentals.